Biotop-report 2011

35

B i o T O P i c s   4 2 _

B i o T O P   R e p o r t   2 0 1 1

New Biotech Companies

Aevotis GmbH

aevotis.com

The core competencies of aevotis lie in the targeted conversion of simple carbohydrate containing substrates (e. g. agricultural by-products, 

waste streams, inexpensive sugars) to high-value carbohydrate based products, their characterization, processing and testing. Marketable 

products include novel /optimized enzymes, expression systems, specialized biotransformation and down-stream processes, customized 

oligomers and polymers for food and non-food uses.

Alacris Theranostics GmbH

alacris.de

The company is based on novel translational medicine/systems biology technology developed at the Max Planck Institute for Molecular 

Genetics in Berlin coupled with preferential access to the world’s most cost effective sequencing and genotyping technology. The scientific 

founders are among the world’s foremost experts in sequencing technology, systems biology and bio-medicine.Alacris Theranostics offers 

its services internationally in Europe and North America.

BG Berlin-Genetics GmbH

bg-berlin-genetics.de

BG Berlin-Genetics GmbH is a new provider for genetic diagnostics and consulting in genetic diagnostics. We are a team of experienced 

human geneticists and have worked for many years in the field of human genetic science and human genetic diagnostics. Our aim is the 

development of innovative cooperation concepts, to connect classical patient-based medical care centers with modern technology-based 

service centers. In future, these cooperation forms will enable efficient, high quality, and patient-based genetic diagnostics.

BioSilta Europe GmbH

biosilta.com

BioSilta is an international company that specializes in advanced tools for microbial cell cultivation, protein production, enzyme screening 

and food spoilage testing. The patented EnBase

®

 technology resembles fed-batch mode and provides a cultivation environment with glu-

cose-control, pH maintenance and inhibition of growth-limiting metabolites without the need for traditional mechanical pumps. EnBase

®

 

is provided in ready-to-use liquid or tablet products. BioSilta specializes in small-scale cultures and its products offer customer solutions 

from multi-well plates to small-scale bioreactors. 

Botiss medical AG

botiss.com

Botiss biomaterials is a privately owned biotech company, headquartered in Berlin. botiss is the leading German specialist for dental bone 

and tissue regeneration (BTR). We focus on the de velopment of innovative regenerative materials and clinical marketing/distribution in over 

50 countries world-wide. The botiss subsidiary Cell+Tissue Bank Austria is a leading European manufacturer of allogenic materials for hard 

tissue regeneration.

Epinamics GmbH

epinamics.com

Epinamics GmbH, a newly established Berlin based pharmaceutical research and development dedicated company, is owner of a proprietary 

film forming formulation technology platform, the ‘Invisible Patch’ system. The system is offering a broad basis for the development of 

formulations for treatment of dermatological diseases as well as for the development of transdermal systems. Currently the development 

of products has been initiated for the topical treatment of vitiligo and the transdermal treatment of e. g. hypogonadism, climacteric com-

plaints, migraine, emesis. The development of these products and of other active ingredients suitable for this technology will be continued 

with partners interested in licensing this technology and/or respective products.

Labor Berlin

laborberlin.com

The company is the service subsidiary of Europe’s largest hospital laboratory for clinical pathology and offers complete solutions for any kind 

of testing for the ivd industry, CROs, the pharmaceutical industry, life science companies and research facilities. Labor Berlin performs over 20 

million analyses in clinical pathology per year; it is the exclusive laboratory partner of Charité - Universitätsmedizin Berlin and the Vivantes 

Network for Health and provides the diagnostics for approximately 9.000 in-house patients a day and over 800.000 out-patients per year.

ORGANOBALANCE 

 Medical  AG

organobalancemedical.

com

ORGANOBALANCE Medical AG funds and promotes the research and development of novel therapies based on specific probiotic cultures, aim-

ing to develop active substances and mechanisms for innovative medicinal products and medical devices, as well as offer new therapeutic 

concepts for hitherto inadequately treatable indications.

Pentracor GmbH

pentracor.com

In the case of cardiac infarction, C-reactive protein (CRP) results in an increase of the primary damage. Based on a new prototype, the com-

pany Pentracor GmbH aims to develop an adsorber for therapeutic reduction of CRP, lead it to approval, establish its certified production 

and market the product after clinical validation.

RENESA UG

renesa.de

Manufacturing and distribution of rapid tests, mainly for medical purposes (Point of Care Testing).

TheraKine BioDelivery 

GmbH

Therakine.com

Development of antibody drug delivery systems and related tasks

UGA Biopharma

ugabiopharma.com

UGA Biopharma, a private research and development company, focuses on research, development and commercialization of biopharmaceu-

tical products under contract with other biopharmaceutical companies. UGA Biopharma conducts power of biosciences to develop high-tech, 

last generation of biomedicine, diagnostic kits, molecular biology items and also offers world class services in biotechnology area.

---